Clinical laboratory testing for the antiphospholipid syndrome

This publication has 77 references indexed in Scilit:

• Lupus anticoagulant testing: improvements in performance in a UK NEQAS proficiency testing exercise after dissemination of national guidelines on laboratory methods
  British Journal of Haematology, 2002
• A chimeric antibody with the human ?1 constant region as a putative standard for assays to detect IgG ?2-glycoprotein I-dependent anticardiolipin and anti-?2-glycoprotein I antibodies
  Arthritis & Rheumatism, 1999
• International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an International workshop
  Arthritis & Rheumatism, 1999
• Do antibodies to β2-glycoprotein 1 contribute to the better characterization of the antiphospholipid syndrome?
  Lupus, 1999
• IgG Anticardiolipin Antibody Titer >40 GPL and the Risk of Subsequent Thrombo-occlusive Events and Death
  Stroke, 1997
• A more specific ELISA assay for the detection of antiphospholipid antibodies
  Clinical Immunology Newsletter, 1995
• β₂‐glycoprotein 1 (β₂GP1) enhances cardiolipin binding activity but is not the antigen for antiphospholipid antibodies
  British Journal of Haematology, 1992
• Lupus‐like anticoagulant properties of murine monoclonal antibodies to β₂‐glycoprotein I
  British Journal of Haematology, 1992
• Coagulation screen is more specific than the anticardiolipin antibody ELISA in defining a thrombotic subset of lupus patients.
  Annals of the Rheumatic Diseases, 1988
• SYNDROME OF THE BLACK SWAN
  Rheumatology, 1987